Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Stop-smoking drug unsafe for pilots
- The Federal Aviation Administration on Wednesday removed the smoking cessation drug Chantix from the list of medications considered safe for pilots and air-traffic controllers after a study linked the medication to mental confusion and other problems that could put passengers at risk. FAA spokesman Les Dorr...
- Research articles 2008-05-22
- Smoking Cessation Market Fired up with the Introduction of Chantix
- PALO ALTO, Calif. -- The United States has gradually woken up to the high health hazards of smoking, with approximately 75 percent of the smokers in the country wishing to quit smoking. Realizing that it has the most easily avoidable reason for mortality, city and state governments have passed numerous...
- Research articles 2008-02-25
- Free & Clear® Data Shows Effectiveness of Chantix™ When Used in Combination with Phone-Based Behavioral Counseling
- SEATTLE -- Free & Clear, Inc., the national leader in evidence-based tobacco cessation programs delivered via the phone and internet, today released an analysis of data from nearly 8000 participants that shows Varenicline, marketed as Chantix, is an effective tool for quitting tobacco when used in conjunction with intensive phone-based...
- Research articles 2008-06-05
- Pfizer Statement on CHANTIX Labeling Update in the United States
- NEW YORK -- Cigarette smoking is associated with significant morbidity and mortality. Smoking is the leading preventable cause of disease and premature death in the United States, with more than 438,000 U.S. deaths annually attributable to smoking. Patients who smoke cigarettes should be counseled to quit. CHANTIX[R] was approved in...
- Research articles 2008-01-18
- US smokers to access new treatment.
- Nov 03, 2006 (New Zealand Pharmacy - ABIX via COMTEX) -- The US Food & Drug Administration FDA has approved its first smoking cessation product in nearly 10 years. Pfizer's varenicline (sold as "Chantix") received priority review des Nov 03, 2006 (New Zealand Pharmacy -...
- Research articles 2006-11-03
- Pfizer Flails As Chantix Chokes
- When a cash-cow drug like Pfizer's smoking-cessation treatment Chantix comes under fire for alleged side effects, the pharma response always seems to be the same -- circle the wagons and deny, deny, deny. The only problem? Making like the tobacco industry in its heydey doesn't seem to...
- Blog posts 2008-06-02
- Pfizer Spins, And Spins Some More on Chantix
- Last week, Pfizer held its promised "media roundtable" to address a rising chorus of concern about its anti-smoking drug Chantix. Reports from Pharmalot and the WSJ Health Blog suggest that Pfizer and its spokespeople offered exactly the kind of circle-the-wagons defense I'd predicted. From the WSJ blog, Pfizer's main talking...
- Blog posts 2008-06-09
- Pfizer and Chantix: From Bad to Worse
- Much as I suspected when I first wrote about Pfizer's attempts to minimize potentially serious neurological side effects of its smoking-cessation drug Chantix, the drugmaker's stonewalling tactics have simply made a bad situation worse. To wit: John Spangler, director of Tobacco Intervention Programs at Wake Forest University,...
- Blog posts 2008-06-17
Additional Resources
- Europeans Chew on Pfizer's Chantix as Americans Turn Away
- Pfizer's smoking cessation product, Chantix, seems to be going down the path of Exubera in the U.S.: Sales were down 49 percent to $96 million in America, and down globally by 24 percent to $182 million, making it a marginal drug for Pfizer. But in foreign territories,...
- Blog posts 2008-10-22
- Pharma Roundup: Sanofi in China, Wyeth and Fen-Phen, Chantix Problems, and More
- Special "While Merck Was Slashing Jobs" Edition: Sanofi-Aventis boosts R&D program in China, Wyeth still paying for Fen-Phen, Chantix blamed for 1,001 Q1 injuries, one in four biotech drugs cause dangerous side effects. by John Maas
- Blog posts 2008-10-22
- Pharma Roundup: AstraZeneca's Crestor Success, Pfizer's Chantix Problems, and More
- Highly encouraging results on AZ's Crestor, UK drug regulators echo Chantix suicide concerns, OTC drug marketers struggle, Lilly CEO highlights three "gorillas" dogging pharma. by John Maas
- Blog posts 2008-11-10
- Pfizer's Smoking Cessation Medicine Chantix(TM) (Varenicline) Receives FDA Approval and Johnson & Johnson to Participate in the Banc of America Securities Health Care Conference 2006.
- M2 PRESSWIRE-12 May 2006-US Financial Network: Pfizer's Smoking Cessation Medicine ChantixTM Varenicline Receives FDA Approval and Johnson & Johnson to Participate in the Banc of America Securities Health Care Conference 2006C1994-2006 M2 COMMUNICATIONS LTD RDATE:12052006 City of Industry, CA - Pharmaceuticals...
- Research articles 2006-05-12
- Chantix Puffs up Market for Smoking Cessation in the US.
- M2 PRESSWIRE-16 January 2008-Research and Markets: Chantix Puffs up Market for Smoking Cessation in the USC1994-2008 M2 COMMUNICATIONS LTD RDATE:17012008 Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c79700) has announced the addition of Frost & Sullivan's new report: U.S. Smoking ...
- Research articles 2008-01-16
- Nabi Biopharmaceuticals Q4 2007 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Your first question comes from Stephen Dunn with Dawson James. Please proceed with your question. Stephen Dunn - Dawson James Good afternoon. Thanks for taking my questions. Raafat Fahim Thanks, Stephen. Stephen Dunn - Dawson James I guess we still have $48.5 million left on...
- Earnings calls 2008-03-17
- 14 Drug Companies Cited for Misleading Google Ads
- The FDA cited 14 drug companies for misleading advertising in sponsored ads among Google search results. Those cited: Biogen Idec, Sanofi Aventis, GlaxoSmithKline, Forest Laboratories, Cephalon, Bayer, Johnson & Johnson, Pfizer, Novartis , Genentech, Boehringer Ingelheim, Merck, Hoffman-LaRoche, and Eli Lilly. The citations, sent...
- Blog posts 2009-04-07
- PFIZER INC - Regulatory Approval.
- Pfizer's Smoking Cessation Medicine ChantixTM Varenicline Receives FDA Approval * First new prescription treatment approved...
- Research articles 2006-05-11
- Pfizer Paid Medical Director for State-Funded Anti-Smoking Campaign
- UPDATE: The doctor at the center of the report says his roll was misrepresented, and that there was no overlap between his time at Pfizer and the anti-smoking project he later led. See comments section below for full statement. The medical director of a state-funded anti-smoking project...
- Blog posts 2009-01-12
- Advertising Roundup: Super Bowl Audience Declined; Sex Pistol's Butter Ad; BMW Review; Cliff Freeman Gets Airline; More ...
- Super Bowl more expensive for advertisers, got fewer viewers -- NBC said it sold out its entire available ad inventory on the Super Bowl last night, notching $206 million, up from $186.3 million sold by News Corp.'s Fox for the 2008 game. The game got 97 million viewers last year,...
- Blog posts 2009-02-03
- Nabi Biopharmaceuticals Q3 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Your first question comes from Sanjay Dori [ph] from Deutsche Bank, please proceed. Sanjay Dori - Deutsche Bank Hi, just there were some news in the last 48 hours about Pfizer’s smoking cessation drugs having some better data, how does that affect you and where...
- Earnings calls 2009-11-05
- Pfizer, CDM clean up at Doctors' Choice
- PROFESSIONAL ADS for Pfizer's Chantix and Organon's NuvaRing were the year's top-rated as judged by physicians in the Association of Medical Media's fifth annual Doctors' Choice Awards.
- Research articles 2007-11-01
- << Previous
- page 1 of 1
- Next >>
Content Types
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
